Veracyte Inc. (VCYT)

Business: Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery.

IPO Date: 30-Oct-2013

Co-Founder & Exec. Chairwoman: Ms. Bonnie H. Anderson

CEO & Director: Mr. Marc A. Stapley

Listing: NASDAQ: VCYT

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.veracyte.com

Market cap: $1,426.76 Mln

Revenue (TTM): $250.59 Mln

Earnings (TTM): $-48.16 Mln

Cash: $163.62 Mln

Total Debt: $18.41 Mln

Insider's Holding: 0.74%

Liquidity: Low

52 Week range: $14.92 - 54.13

Shares outstanding: 71,445,296

10 Years Aggregate:

• CFO: $-190.91 Mln
• EBITDA: $-266.81 Mln
• Net Profit: $-315.74 Mln